Prevention of Heart Damage During Anthracycline Cancer Chemotherapy
Prevention of Heart Damage During Anthracycline Cancer Chemotherapy
批准号:
nhmrc : GNT1145776
负责人:
A/Pr Benedetta Sallustio
金额:
$32.72万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-01-01 至 --
中文摘要
阿霉素是一种广泛用于治疗癌症的有效药物。然而,它会导致心脏损伤,这不仅会造成新的健康问题,而且会限制癌症患者可以接受的阿霉素治疗的时间,从而限制癌症治愈的可能性。因此,预防多柔比星对心脏的损害对于提高癌症的总体治愈率和患者的健康非常重要。这项研究旨在开发新的药物来预防癌症化疗期间的心脏损伤。
英文摘要
Doxorubicin is an effective medicine widely used for the treatment of cancer. However, it can cause heart damage, which not only creates a new health problem, but also limits the length of doxorubicin treatment cancer patients can receive, and therefore the likelihood of cancer cure. Preventing heart damage by doxorubicin is therefore important to improve overall cancer cure rates and patient health. This study aims to develop new medications to prevent heart damage during cancer chemotherapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prevention of Heart Damage During Anthracycline Cancer Chemotherapy
-
批准号:nhmrc : 1145776
-
项目类别:Project Grants
-
资助金额:$22.12万
-
财政年份:2018
-
负责人:A/Pr Benedetta Sallustio
-
依托单位:
Pharmacogenomics of renal transplantation
-
批准号:nhmrc : 565038
-
项目类别:NHMRC Project Grants
-
资助金额:$23.89万
-
财政年份:2009
-
负责人:A/Pr Benedetta Sallustio
-
依托单位:
Novel mechanisms of genotoxicity: bioactivation of carboxylic acid drugs by UDP-glucuronosyltransferases
-
批准号:nhmrc : 250320
-
项目类别:NHMRC Project Grants
-
资助金额:$13.65万
-
财政年份:2003
-
负责人:A/Pr Benedetta Sallustio
-
依托单位:
国内基金
海外基金
e-Heart仿真平台及关键技术研究
-
批准号:60571025
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2005
-
负责人:王宽全
-
依托单位: